Cardiovascular Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Endovasc, Inc.
Craig J. Hartley, PhD, rejoins company's scientific advisory committee
April 26th, 2005
Endovasc, Inc., (EVSC), an early-stage drug-development company that develops new cardiovascular and metabolic drug therapies, announced that Craig J. Hartley, PhD, has rejoined the company's scientific advisory committee. Hartley is currently a professor of cardiovascular sciences in the department of medicine of Baylor College of Medicine in Houston, Texas. Since 1970, Hartley has been involved in the design, development, application, and commercialization of ultrasonic instrumentation for cardiovascular measurements. A major interest has been the miniaturization of ultrasonic sensors for catheter and implantable devices used in both clinical and...
Source: Cardiovascular Business Week (2005-04-26)
|
